Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Tenet Healthcare Corporation — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Tenet Healthcare Corporation trades at $277.39 (market cap $21.87B). The key difference: Tenet Healthcare Corporation is far larger — about 22.4× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, Maravai LifeSciences Holdings Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Tenet Healthcare Corporation for 16 Days on average.
| MRVI | THC | |
|---|---|---|
Market Cap | $977.37M | $21.87B |
Volume | 2,742,564 | 717,275 |
Sector | Health | Health |
52-Week High | $9.00 | $280.77 |
52-Week Low | $2.83 | $161.37 |
Typical Hold Time | 0 Days | 16 Days |
Enterprise Value | $1.08B | $32.95B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Tenet Healthcare (THC) trades at $266.91, down 0.69% on the day, with strong fundamental performance including three consecutive quarterly earnings beats. The stock maintains bullish technical signals with key support at $265 and resistance at $271. Revenue growth continues despite softer surgical volumes, driven by higher revenue per case and favorable service mix. Analyst consensus remains overwhelmingly positive with 81% buy ratings and a $283.36 price target representing 6% upside potential.
THC presents a compelling investment case with attractive valuation metrics (P/E 10.5, EV/EBITDA 5.91) and strong profitability (ROE 53.31%, net margin 9.9%). The company's expanding capital-return strategy is supported by robust cash flow, though growth investments and capital needs require monitoring. Key risks include execution challenges and healthcare regulatory uncertainty, but the fundamental outlook remains positive with expected revenue growth to $22.6B and net profit margin expansion to 9.89% in 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
